Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.

DeCuir J, Payne AB, Self WH, Rowley EAK, Dascomb K, DeSilva MB, Irving SA, Grannis SJ, Ong TC, Klein NP, Weber ZA, Reese SE, Ball SW, Barron MA, Naleway AL, Dixon BE, Essien I, Bride D, Natarajan K, Fireman B, Shah AB, Okwuazi E, Wiegand R, Zhu Y, Lauring AS, Martin ET, Gaglani M, Peltan ID, Brown SM, Ginde AA, Mohr NM, Gibbs KW, Hager DN, Prekker M, Mohamed A, Srinivasan V, Steingrub JS, Khan A, Busse LW, Duggal A, Wilson JG, Chang SY, Mallow C, Kwon JH, Exline MC, Columbus C, Vaughn IA, Safdar B, Mosier JM, Harris ES, Casey JD, Chappell JD, Grijalva CG, Swan SA, Johnson C, Lewis NM, Ellington S, Adams K, Tenforde MW, Paden CR, Dawood FS, Fleming-Dutra KE, Surie D, Link-Gelles R, CDC COVID-19 Vaccine Effectiveness Collaborators

Open source

DOI
10.15585/mmwr.mm7308a5
Published
2024 Feb 29
Container
MMWR. Morbidity and mortality weekly report
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15585/mmwr.mm7308a5,
  title = {Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.},
  author = {DeCuir J and Payne AB and Self WH and Rowley EAK and Dascomb K and DeSilva MB and Irving SA and Grannis SJ and Ong TC and Klein NP and Weber ZA and Reese SE and Ball SW and Barron MA and Naleway AL and Dixon BE and Essien I and Bride D and Natarajan K and Fireman B and Shah AB and Okwuazi E and Wiegand R and Zhu Y and Lauring AS and Martin ET and Gaglani M and Peltan ID and Brown SM and Ginde AA and Mohr NM and Gibbs KW and Hager DN and Prekker M and Mohamed A and Srinivasan V and Steingrub JS and Khan A and Busse LW and Duggal A and Wilson JG and Chang SY and Mallow C and Kwon JH and Exline MC and Columbus C and Vaughn IA and Safdar B and Mosier JM and Harris ES and Casey JD and Chappell JD and Grijalva CG and Swan SA and Johnson C and Lewis NM and Ellington S and Adams K and Tenforde MW and Paden CR and Dawood FS and Fleming-Dutra KE and Surie D and Link-Gelles R and CDC COVID-19 Vaccine Effectiveness Collaborators},
  year = {2024},
  journal = {MMWR. Morbidity and mortality weekly report},
  doi = {10.15585/mmwr.mm7308a5},
  url = {https://doi.org/10.15585/mmwr.mm7308a5}
}

RIS

TY  - JOUR
TI  - Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.
AU  - DeCuir J
AU  - Payne AB
AU  - Self WH
AU  - Rowley EAK
AU  - Dascomb K
AU  - DeSilva MB
AU  - Irving SA
AU  - Grannis SJ
AU  - Ong TC
AU  - Klein NP
AU  - Weber ZA
AU  - Reese SE
AU  - Ball SW
AU  - Barron MA
AU  - Naleway AL
AU  - Dixon BE
AU  - Essien I
AU  - Bride D
AU  - Natarajan K
AU  - Fireman B
AU  - Shah AB
AU  - Okwuazi E
AU  - Wiegand R
AU  - Zhu Y
AU  - Lauring AS
AU  - Martin ET
AU  - Gaglani M
AU  - Peltan ID
AU  - Brown SM
AU  - Ginde AA
AU  - Mohr NM
AU  - Gibbs KW
AU  - Hager DN
AU  - Prekker M
AU  - Mohamed A
AU  - Srinivasan V
AU  - Steingrub JS
AU  - Khan A
AU  - Busse LW
AU  - Duggal A
AU  - Wilson JG
AU  - Chang SY
AU  - Mallow C
AU  - Kwon JH
AU  - Exline MC
AU  - Columbus C
AU  - Vaughn IA
AU  - Safdar B
AU  - Mosier JM
AU  - Harris ES
AU  - Casey JD
AU  - Chappell JD
AU  - Grijalva CG
AU  - Swan SA
AU  - Johnson C
AU  - Lewis NM
AU  - Ellington S
AU  - Adams K
AU  - Tenforde MW
AU  - Paden CR
AU  - Dawood FS
AU  - Fleming-Dutra KE
AU  - Surie D
AU  - Link-Gelles R
AU  - CDC COVID-19 Vaccine Effectiveness Collaborators
PY  - 2024
JO  - MMWR. Morbidity and mortality weekly report
DO  - 10.15585/mmwr.mm7308a5
UR  - https://doi.org/10.15585/mmwr.mm7308a5
ER  - 

APA

J, D., AB, P., WH, S., EAK, R., K, D., MB, D., SA, I., SJ, G., TC, O., NP, K., ZA, W., SE, R., SW, B., MA, B., AL, N., BE, D., I, E., D, B., K, N., B, F., AB, S., E, O., R, W., Y, Z., AS, L., ET, M., M, G., ID, P., SM, B., AA, G., NM, M., KW, G., DN, H., M, P., A, M., V, S., JS, S., A, K., LW, B., A, D., JG, W., SY, C., C, M., JH, K., MC, E., C, C., IA, V., B, S., JM, M., ES, H., JD, C., JD, C., CG, G., SA, S., C, J., NM, L., S, E., K, A., MW, T., CR, P., FS, D., KE, F., D, S., R, L., & Collaborators, C. C. V. E. (2024). Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.. MMWR. Morbidity and mortality weekly report. https://doi.org/10.15585/mmwr.mm7308a5

Source records